As of 2025-07-09, the EV/EBITDA ratio of Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336.SS) is 133.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 688336.SS's latest enterprise value is 32,134.82 mil CNY. 688336.SS's TTM EBITDA according to its financial statements is 241.24 mil CNY. Dividing these 2 quantities gives us the above 688336.SS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 23.1x - 28.8x | 26.3x |
| Forward P/E multiples | 11.0x - 19.3x | 14.8x |
| Fair Price | 9.42 - 17.84 | 12.22 |
| Upside | -82.1% - -66.0% | -76.7% |
| Date | EV/EBITDA |
| 2025-04-29 | 73.74 |
| 2025-04-28 | 74.89 |
| 2025-04-25 | 75.88 |
| 2025-04-24 | 76.09 |
| 2025-04-23 | 73.20 |
| 2025-04-22 | 74.66 |
| 2025-04-21 | 72.48 |
| 2025-04-18 | 68.65 |
| 2025-04-17 | 68.19 |
| 2025-04-16 | 69.26 |
| 2025-04-15 | 71.87 |
| 2025-04-14 | 73.48 |
| 2025-04-11 | 68.37 |
| 2025-04-10 | 67.70 |
| 2025-04-09 | 63.54 |
| 2025-04-08 | 63.10 |
| 2025-04-07 | 61.62 |
| 2025-04-03 | 68.93 |
| 2025-04-02 | 73.12 |
| 2025-04-01 | 73.71 |
| 2025-03-31 | 70.44 |
| 2025-03-28 | 70.03 |
| 2025-03-27 | 68.57 |
| 2025-03-26 | 67.88 |
| 2025-03-25 | 70.67 |
| 2025-03-24 | 70.34 |
| 2025-03-21 | 69.98 |
| 2025-03-20 | 72.71 |
| 2025-03-19 | 73.89 |
| 2025-03-18 | 72.87 |
| 2025-03-17 | 68.67 |
| 2025-03-14 | 68.93 |
| 2025-03-13 | 67.22 |
| 2025-03-12 | 67.01 |
| 2025-03-11 | 68.88 |
| 2025-03-10 | 69.67 |
| 2025-03-07 | 68.01 |
| 2025-03-06 | 68.80 |
| 2025-03-05 | 68.80 |
| 2025-03-04 | 66.25 |
| 2025-03-03 | 67.45 |
| 2025-02-28 | 66.45 |
| 2025-02-27 | 65.40 |
| 2025-02-26 | 63.92 |
| 2025-02-25 | 61.85 |
| 2025-02-24 | 61.75 |
| 2025-02-21 | 66.09 |
| 2025-02-20 | 58.81 |
| 2025-02-19 | 57.73 |
| 2025-02-18 | 56.79 |